Unimedia Pharmaceuticals Private Limited

This company manufactures pharmaceutical, medicinal, chemical, and botanical products in various forms.

2013 | Ahmedabad, Gujarat (India) | Active
Last Updated:

Unimedia Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 12 Year, 2 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 6.06 M
  • Revenue Growth 5.49%
  • Profit Growth 134.63%
  • Ebitda 37.06%
  • Net Worth 17.18%
  • Total Assets 5.59%

About Unimedia Pharmaceuticals

Unimedia Pharmaceuticals Private Limited (UPPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 March 2013 and has a history of 12 years and two months. Its registered office is in Ahmedabad, Gujarat, India.

The Corporate was formerly known as Aqsa Remedies Private Limited. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.

The company currently has active open charges totaling ₹6.06 M.

Mohammadzahid Mall and Abdulrashid Mall serve as directors at the Company.

Company Details

  • Location

    Ahmedabad, Gujarat, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24233GJ2013PTC074110

  • Company No.

    074110

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    21 Mar 2013

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Ahmedabad

Industry

Pharma

What products or services does Unimedia Pharmaceuticals Private Limited offer?

Unimedia Pharmaceuticals Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Antacid Drugs, Pain Relief Drugs & Pharmaceuticals, Diclofenac, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Common Disease Medicines, Antihistamines, Third Party Manufacturing Consultancy, Pharmaceutical Contract Manufacturing Services.

Company report

Unimedia Pharmaceuticals Private Limited

Explore comprehensive data for Unimedia Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Unimedia Pharmaceuticals?

Board Members (2)

NameDesignationAppointment DateStatus
Mohammadzahid Mall Country flag representing In Director 21-Mar-2013Current
Abdulrashid Mall Country flag representing In Director 21-Mar-2013Current

Financial Performance of Unimedia Pharmaceuticals.

Unimedia Pharmaceuticals Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 5.49% increase. The company also saw a substantial improvement in profitability, with a 134.63% increase in profit. The company's net worth Soared by an impressive increase of 17.18%.

Unimedia Pharmaceuticals revenue growth over time
Unimedia Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
5.49%
Revenue from Operations
5.43%
Total Assets
5.59%
Profit or Loss
134.63%
Net Worth
17.18%
EBITDA
37.06%

What is the Ownership and Shareholding Structure of Unimedia Pharmaceuticals?

Unlock access to Unimedia Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹6.06 M

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Others : 0.61 Cr

Latest Charge Details

DateLenderAmountStatus
07 Nov 2023Others₹0.93 MOpen
15 Nov 2019Others₹0.90 MOpen
18 Nov 2013Others₹4.23 MOpen

How Many Employees Work at Unimedia Pharmaceuticals?

Unlock and access historical data on people associated with Unimedia Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Unimedia Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Unimedia Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unimedia Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Unimedia Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Unimedia Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Unimedia Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.

  • Charges

    A charge with Others amounted to Rs. 0.93 M with Charge ID 100836944 was registered on 07 Nov 2023.

  • Charges

    A charge with Others of Rs. 4.23 M registered on 18 Nov 2013 with Charge ID 10466940 was modified on 14 Jul 2020.

  • Charges

    A charge with Others amounted to Rs. 0.90 M with Charge ID 100320020 was registered on 15 Nov 2019.

  • Charges

    A charge with Others amounted to Rs. 4.23 M with Charge ID 10466940 was registered on 18 Nov 2013.

Frequently asked questions

  • What is the Incorporation or founding date of Unimedia Pharmaceuticals Private Limited?

    Unimedia Pharmaceuticals Private Limited was incorporated on 21 Mar 2013.

  • What is authorized share capital and paid-up capital of Unimedia Pharmaceuticals Private Limited?

    The authorized share capital of Unimedia Pharmaceuticals Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.50 M.

  • Who are the current board members & directors of Unimedia Pharmaceuticals Private Limited?

    Currently 2 directors are associated with Unimedia Pharmaceuticals Private Limited.

    • Mohammadzahid Abdulrashid Mall
    • Abdulrashid Abdulmajid Mall
  • What is the registered address of Unimedia Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Unimedia Pharmaceuticals Private Limited is Plot 1706 Phase Iii, Gidc Vatva India, Ahmedabad, Gujarat, 382445.

  • What is the corporate identification number (CIN) and company number of Unimedia Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Unimedia Pharmaceuticals Private Limited is U24233GJ2013PTC074110 and the company number is 074110 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Unimedia Pharmaceuticals Private Limited?

    According to the financial reports for the fiscal year 2024, the revenue trend for Unimedia Pharmaceuticals Private Limited has risen by 5.49%.

  • What change has been observed in the net worth of Unimedia Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2024 indicates that The net worth of Unimedia Pharmaceuticals Private Limited has experienced an upsurge of 17.18%.

  • What are the total open charges for Unimedia Pharmaceuticals Private Limited?

    As per the financial statements for fiscal Year 2024, The total open charges for Unimedia Pharmaceuticals Private Limited amount to ₹ 6.06 M.

  • When was the last Balance Sheet of Unimedia Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Unimedia Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial